Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Opiranserin (VVZ-149) hydrochloride is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A), with IC50s of 0.86 and 1.3 μM, respectively. It shows antagonistic activity on rP2X3 (IC50=0.87 μM). It is development as an injectable agent for the treatment of postoperative pain.
Description | Opiranserin (VVZ-149) hydrochloride is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A), with IC50s of 0.86 and 1.3 μM, respectively. It shows antagonistic activity on rP2X3 (IC50=0.87 μM). It is development as an injectable agent for the treatment of postoperative pain. |
Targets&IC50 | GlyT2:0.86 μM, 5-HT2A Receptor:1.3 μM, rP2X3:0.87 μM |
Molecular Weight | 430.97 |
Formula | C21H35ClN2O5 |
CAS No. | 1440796-75-7 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Opiranserin hydrochloride 1440796-75-7 VVZ 149 analgesic postoperative VVZ-149 5-hydroxytryptamine Receptor 5-HT Receptor anti-inflammatory Serotonin Receptor Inhibitor pain GlyT Opiranserin non-opioid inhibit P2X Receptor P2XRs VVZ149 Glycine transporters inhibitor